The serum concentrations of procollagen propeptides in hypertensive patients with or without diabetes

Acta Cardiologica Sinica

Volumn 24, Issue 4, 2008, Pages 198-203

  Wang, Yu Chen ^a   Lee, Jen Kuang ^a   Lin, Wei Cheng ^a   Wu, Vin Cent ^a   Hung, Chi Sheng ^a   Liao, Lin Chu ^a   Hsein, Yenh Chen ^a   Kao, Hsien Li ^a   Chao, Chia Lun ^a   Wang, Tzung Dau ^a   Lin, Yen Hung ^a   Ho, Yi Lwun ^a,b   Chen, Ming Fong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Hypertension; Myocardial fibrosis; PIIINP; PINP

Indexed keywords

PEPTIDE; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; PEPTIDE ANALYSIS; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 60749137638     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Heeneman S, Cleutjens JP, Faber BC, et al. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol 2003;200(4):516-25.
2. Lopez B, Gonzalez A, Varo N, et al. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001;38(5):1222-6.
3. Lombardi R, Betocchi S, Losi MA, et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 2003; 108(12):1455-60.
4. Uusimaa P, Risteli J, Niemela M, et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 1997;96(8):2565- 72.
5. Weber KT. Monitoring tissue repair and fibrosis from a distance. Circulation 1997;96(8):2488-92.
6. Laviades C, Varo N, Fernandez J, et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998;98(6):535-40.
7. Sato Y, Kataoka K, Matsumori A, et al. Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 1997;78(5):505-8.
8. Klappacher G, Franzen P, Haab D, et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 1995;75(14):913-8.
9. Lin YH, Ho YL, Wang TD, et al. The relation of amino-terminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction or hibernation. Clin Biochem 2006;39(9):861-6.
10. Fassbach M, Schwartzkopff B. Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction. Z Kardiol 2005;94(5):328-35.
11. Elsasser A, Vogt AM, Nef H, et al. Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol 2004;43(12):2191-9.
12. Poulsen SH, Host NB, Jensen SE, Egstrup K. Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation 2000;101(13):1527-32.
13. Cicoira M, Rossi A, Bonapace S, et al. Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. J Card Fail 2004;10(5):403-11.
14. Lin YH, Chiu YW, Shiau YC, et al. The relation between serum level of amioterminal propeptide of type I procollagen and diastolic dysfunction in hypertensive patients without diabetes mellitus: A pilot study. J Hum Hypertens 2006;20(12):964-7.
15. Chuang SY, Chen CH, Chou P. Hypertension and the insulin-related metabolic syndrome: factor analysis in 17,539 Taiwanese. Acta Cardiol Sin 2004;20:229-36
16. Reddi AS. Collagen metabolism in the myocardium of normal and diabetic rats. Exp Mol Pathol 1988;48(2):236-43.
17. Shimizu M, Umeda K, Sugihara N, et al. Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 1993;46(1): 32-6.
18. Watts GF, Marwick TH. Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance. Clin Sci (Lond) 2003;105(5):537-40.
19. Alla F, Kearney-Schwartz A, Radauceanu A, et al. Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes. Eur J Heart Fail 2006;8(2): 147-53.
20. Yamamoto K, Masuyama T, Sakata Y, et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hyper-trophy in hypertensive heart. Cardiovasc Res 2002;55(1):76-82.
21. Varo N, Etayo JC, Zalba G, et al. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. J Hypertens 1999; 17(1):107-14.
22. Sekita S, Katagiri T, Sasai Y, Takeda K. Studies on collagen in the experimental myocardial infarction. Jpn Circ J 1985;49(2): 171-8.
23. Melkko J, Niemi S, Risteli L, Risteli J. Radimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990;36(7):1328-32.
24. Querejeta R, Lopez B, Gonzalez A, et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 2004;110(10): 1263-8.
25. Lin YH, Liu CP, Hsu RB, et al. Association of amino-terminal propeptide of type III procollagen and acute myocardial rejection in male patients receiving heart transplantation. Clin Chem Lab Med 2007;45(8):1004-8.
26. Diez J, Lopez B, Gonzalez A, Querejeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 2001;16(6): 328-35.
27. Lin YH, Shiau YC, Yen RF, et al. The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients. Ultrasound Med Biol 2004;30(7):885-91.
28. Querejeta R, Varo N, Lopez B, et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000;101(14): 1729-35.
29. Benazzoug Y, Borchiellini C, Labat-Robert J, et al. Effect of high-glucose concentrations on the expression of collagens and fibronectin by fibroblasts in culture. Exp Gerontol 1998;33(5): 445-55.
30. Balint E, Szabo P, Marshall CF, Sprague SM. Glucose-induced inhibition of in vitro bone mineralization. Bone 2001;28(1): 21-8.
31. Spanheimer RG, Umpierrez GE, Stumpf V. Decreased collagen production in diabetic rats. Diabetes 1988;37(4):371-6.